Community post
A new Transplant Infectious Diseases study by Ghady Haidar (University of Pittsburgh School of Medicine) and colleagues reports the use of nebulized phage therapy to treat Burkholderia multivorans in a CF patient. Unfortunately this was a clinical failure, but highlights the limitations, unknowns, and challenges of phage therapy for resistant infections.
Topics
| Source | Capsid & Tail #215 |
|---|